The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Utility of hemoglobin A1c in predicting diabetes risk
Open accessAbstract
Background There is controversy surrounding the issue of whether, and how, to screen adults for type 2 diabetes. Our objective was to measure the incidence of new diabetes among outpatients enrolled in a health care system, and to determine whether hemoglobin A1c (HbA1c) values would allow risk stratification for patients' likelihood of developing diabetes over 3 years.Methods We conducted a prospective cohort study with 3-year follow-up at a single large, tertiary care, Department of Veterans Affairs Medical Center (VAMC). A convenience sample of 1,253 outpatients without diabetes, age 45 to 64, with a scheduled visit at the VAMC, were screened for diabetes using an initial HbA1c measurement. All subjects with HbA1c > or = 6.0% (normal, 4.0% to 6.0%) were invited for follow-up fasting plasma glucose (FPG). We then surveyed patients annually for 3 years to ascertain interval diagnosis of diabetes by a physician. The baseline screening process was repeated 3 years after initial screening. After the baseline screening, new cases of diabetes were defined as either the self-report of a physician's diagnosis of diabetes, or by HbA1c > or = 7.0% or FPG > or = 7.0 mmol/L at 3-year follow-up. The incidence of diabetes was calculated as the number of new cases per person-year of follow-up.Results One thousand two hundred fifty-three patients were screened initially, and 56 (4.5%) were found to have prevalent unrecognized diabetes at baseline. The 1,197 patients without diabetes at baseline accrued 3,257 person-years of follow-up. There were 73 new cases of diabetes over 3 years of follow-up, with an annual incidence of 2.2% (95% confidence interval [CI], 1.7% to 2.7%). In a multivariable logistic regression model, baseline HbA1c and baseline body mass index (BMI) were the only significant predictors of new onset diabetes, with HbA1c having a greater effect than BMI. The annual incidence of diabetes for patients with baseline HbA1c < or = 5.5 was 0.8% (CI, 0.4% to 1.2%); for HbA1c 5.6 to 6.0, 2.5% (CI, 1.6% to 3.5%); and for HbA1c 6.1 to 6.9, 7.8% (CI, 5.2% to 10.4%). Obese patients with HbA1c 5.6 to 6.0 had an annual incidence of diabetes of 4.1% (CI, 2.2% to 6.0%).Conclusions HbA1c testing helps predict the likelihood that patients will develop diabetes in the future. Patients with normal HbA1c have a low incidence of diabetes and may not require rescreening in 3 years. However, patients with elevated HbA1c who do not have diabetes may need more careful follow-up and possibly aggressive treatment to reduce the risk of diabetes. Patients with high-normal HbA1c may require follow-up sooner than 3 years, especially if they are significantly overweight or obese. This predictive value suggests that HbA1c may be a useful test for periodic diabetes screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, incidence of diabetes in people with A1C levels in this range is more than 10 times that of people with lower levels (4–7).”
From Diagnosis and classification of diabetes mellitus (2013) · cites this paper as [4]
In the citing paper
“Prospective studies indicate that people within the A1C range of 5.5–6.0% have a 5-year cumulative incidence of diabetes that ranges from 12 to 25% (4–7), which is appreciably (three- to eightfold) higher than incidence in the U.S. population as a whole (8).”
From Diagnosis and classification of diabetes mellitus (2013) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,023
Research works printed but not linked: 1
- Lawson ML, Gerstein HC, Tsui E, Zinman B. Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. Diabetes Care. 1999;22(S1):B35-B39.
Cited by
Sorted by citations
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 14,094
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s067 · Cited by 2,245
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc12-s064 · Cited by 1,539
A new look at screening and diagnosing diabetes mellitus
Saudek, C. D., Herman, W. H., Sacks, D. B., Bergenstal, R. M., Edelman, D., & Davidson, M. B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2174 · Cited by 432
Self-citationA1C level and future risk of diabetes: a systematic review
Zhang, X., Gregg, E. W., Williamson, D. F., Barker, L. E., Thomas, W., Bullard, K. M., Imperatore, G., Williams, D. E., & Albright, A. L. (2010) · Diabetes Care · doi:10.2337/dc09-1939 · Cited by 422
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia
Richter, B., Hemmingsen, B., Metzendorf, M., & Takwoingi, Y. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012661.pub2 · Cited by 298
The epidemic of pre-diabetes: the medicine and the politics
Yudkin, J. S., & Montori, V. M. (2014) · BMJ · doi:10.1136/bmj.g4485 · Cited by 218
Utility of Hemoglobin A1c for Diagnosing Prediabetes and Diabetes in Obese Children and Adolescents
Nowicka, P., Santoro, N., Liu, H., Lartaud, D., Shaw, M. M., Goldberg, R. L., Guandalini, C., Savoye, M., Rose, P., & Caprio, S. (2011) · Diabetes Care · doi:10.2337/dc10-1984 · Cited by 208
Liu, C., Yang, C., Zhao, Y., Ma, Z., Bi, J., Liu, Y., Meng, X., Wang, Y., Cai, J., Kan, H., et al. (2016) · Environment International · doi:10.1016/j.envint.2016.03.028 · Cited by 201
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-11-200806030-00007 · Cited by 185
Sabanayagam, C., Liew, G., Tai, E. S., Shankar, A., Lim, S. C., Subramaniam, T., & Wong, T. Y. (2009) · Diabetologia · doi:10.1007/s00125-009-1360-5 · Cited by 179
Unrecognized glucose intolerance is common in pulmonary arterial hypertension
Pugh, M. E., Robbins, I. M., Rice, T. W., West, J. D., Newman, J. H., & Hemnes, A. R. (2011) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2011.02.016 · Cited by 154
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 164
Mayega, R. W., Guwatudde, D., Makumbi, F. E., Nakwagala, F. N., Peterson, S., Tomson, G. B., & Östenson, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072554 · Cited by 119
Effects of short‐term cinnamon ingestion on in vivo glucose tolerance
Solomon, T. P. J., & Blannin, A. K. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00694.x · Cited by 122
Utility of A1C for Diabetes Screening in the 1999–2004 NHANES Population
Buell, C., Kermah, D., & Davidson, M. B. (2007) · Diabetes Care · doi:10.2337/dc07-0585 · Cited by 161
Identifying Adults at High Risk for Diabetes and Cardiovascular Disease Using Hemoglobin A1c
Ackermann, R. T., Cheng, Y. J., Williamson, D. F., & Gregg, E. W. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.09.022 · Cited by 111
Sato, K. K., Hayashi, T., Harita, N., Yoneda, T., Nakamura, Y., Endo, G., & Kambe, H. (2009) · Diabetes Care · doi:10.2337/dc08-1631 · Cited by 112
Identifying Dysglycemic States in Older Adults: Implications of the Emerging Use of Hemoglobin A1c
Lipska, K. J., de Rekeneire, N., Ness, P. H. V., Johnson, K., Kanaya, A. M., Koster, A., Strotmeyer, E. S., Goodpaster, B. H., Harris, T. B., Gill, T. M., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1171 · Cited by 111
Cederberg, H., Saukkonen, T., Laakso, M., Jokelainen, J. J., Härkönen, P. K., Timonen, M., Keinanen-Kiukaanniemi, S. M., & Rajala, U. (2010) · Diabetes Care · doi:10.2337/dc10-0262 · Cited by 111
Chen, Y., Ahsan, H., Slavkovich, V. N., Peltier, G. L., Gluskin, R. T., Parvez, F., Liu, X., & Graziano, J. H. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901559 · Cited by 100
Wexler, D. J., Nathan, D. M., Grant, R. W., Regan, S., Leuvan, A. L. V., & Cagliero, E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1090 · Cited by 95
Bray, J. W., Kelly, E. L., Hammer, L. B., Almeida, D. M., Dearing, J. W., King, R. B., & Buxton, O. M. (2013) · doi:10.3768/rtipress.2013.mr.0024.1303 · Cited by 93
Elevated A1C in Adults Without a History of Diabetes in the U.S.
Selvin, E., Zhu, H., & Brancati, F. L. (2009) · Diabetes Care · doi:10.2337/dc08-1699 · Cited by 87
Stene, L. C., Barriga, K. J., Hoffman, M., Kean, J., KLINGENSMITH, G. J., Norris, J. M., Erlich, H. A., Eisenbarth, G. S., & Rewers, M. (2006) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2006.00198.x · Cited by 82
Tsenkova, V. K., Carr, D., Schoeller, D. A., & Ryff, C. D. (2010) · Annals of Behavioral Medicine · doi:10.1007/s12160-010-9238-9 · Cited by 92
Gillies, N. A., Pendharkar, S. A., Asrani, V. M., Mathew, J., Windsor, J. A., & Petrov, M. S. (2016) · Pancreatology · doi:10.1016/j.pan.2016.06.661 · Cited by 77
Elevated glycosylated haemoglobin (HbA1c) is a risk marker in coronary artery bypass surgery
Alserius, T., Anderson, R. E., Hammar, N., Nordqvist, T., & Ivert, T. (2008) · Scandinavian Cardiovascular Journal · doi:10.1080/14017430801942393 · Cited by 74
Walid, M. S., Newman, B., Yelverton, J. C., Nutter, J. P., Ajjan, M., & Robinson, J. S. (2009) · Journal of Hospital Medicine · doi:10.1002/jhm.541 · Cited by 75
HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men
Παπάνας, Ν., Steiropoulos, Tzouvelekis, Maltezos, E. S., Trakada, & Bouros, D. E. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s7057 · Cited by 73
Synold, T. W., Xi, B., Wuenschell, G. E., Tamae, D., Figarola, J. L., Rahbar, S., & Termini, J. S. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800224y · Cited by 69
Murali, R., Srinivasan, S., & Ashokkumar, N. (2013) · Biochimie · doi:10.1016/j.biochi.2013.06.013 · Cited by 66
A1C: Recommendations, Debates, and Questions
Bloomgarden, Z. T. (2009) · Diabetes Care · doi:10.2337/dc09-zb12 · Cited by 66
Prediabetes in youths: mechanisms and biomarkers
Weiss, R., Santoro, N., Giannini, C., Galderisi, A., Umano, G. R., & Caprio, S. (2017) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(17)30044-5 · Cited by 71
Ginde, A. A., Cagliero, E., Nathan, D. M., & Camargo, C. A. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0661-6 · Cited by 57
Jayanthy, G., & Subramanian, S. P. (2014) · Biomedicine & Preventive Nutrition · doi:10.1016/j.bionut.2014.03.006 · Cited by 57
Role of Glycated Hemoglobin in the Prediction of Future Risk of T2DM
Abdul‐Ghani, M. A., Abdul‐Ghani, T., Müller, G., Bergmann, A., Fischer, S., Bornstein, S. R., DeFronzo, R. A., & Schwarz, P. E. H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1698 · Cited by 55
Glycated haemoglobin as a predictor for metabolic syndrome in non‐diabetic Korean adults
Sung, K., & Rhee, E. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02146.x · Cited by 52
Silverman, R. A., Thakker, U., Ellman, T., Wong, I., Smith, K. N., Ito, K., & Graff, K. (2011) · Diabetes Care · doi:10.2337/dc10-0996 · Cited by 51
Kaler, S. N., Ralph-Campbell, K., Pohar, S., King, M., Laboucan, C. R., & Toth, E. (2006) · International Journal of Circumpolar Health · doi:10.3402/ijch.v65i5.18139 · Cited by 60
Cosson, E., Hamo-Tchatchouang, E., Banu, I., Nguyen, M. T., Chiheb, S., Ba, H., & Valensi, P. E. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.02.004 · Cited by 46
Hemoglobin A1c as a Predictor of Incident Diabetes
Cheng, P., Neugaard, B. I., Foulis, P., & Conlin, P. R. (2011) · Diabetes Care · doi:10.2337/dc10-0625 · Cited by 43
A Risk Score for Predicting the Incidence of Type 2 Diabetes in a Middle-Aged Korean Cohort
Lim, N.-K., Park, S.-H., Choi, S.-J., Lee, K.-S., & Park, H. (2012) · Circulation Journal · doi:10.1253/circj.cj-11-1236 · Cited by 43
Meo, S. A., Alsubaie, Y., Almubarak, Z., Almutawa, H., AlQasem, Y., & Hasanato, R. M. W. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph121114519 · Cited by 42
Diabetes management in the USA and England: comparative analysis of national surveys
Mainous, A. G., Díaz, V. A., Saxena, S. K., Baker, R., Everett, C. J., Koopman, R. J., & Majeed, A. (2006) · Journal of the Royal Society of Medicine · doi:10.1177/014107680609900918 · Cited by 42
Khosla, L., Bhat, S., Fullington, L. A., & Horlyck-Romanovsky, M. F. (2021) · Preventing Chronic Disease · doi:10.5888/pcd18.200365 · Cited by 40
MAGIC Investigators, Baerenwald, D. A., Bonnefond, A., Bouatia‐Naji, N., Flemming, B. P., Umunakwe, O. C., Oeser, J. K., Pound, L. D., Conley, N. L., Cauchi, S., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2875-3 · Cited by 40
O’Brien, R. M. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0422-8 · Cited by 40
Phytotherapeutic efficacy of the medicinal plant Terminalia catappa L.
Natarajan, D., Rengarajan, R. L., Radhakrishnan, R., Allah, E. F. A., Alqarawi, A. A., Hashem, A., Manikandan, R., & Anand, A. V. (2018) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2018.12.010 · Cited by 39
Type 2 Diabetes Mellitus in Midlife Estimated From the Cambridge Risk Score and Body Mass Index
Thomas, C., Hyppönen, E., & Power, C. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.6.682 · Cited by 37
Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes
Calanna, S., Scicali, R., Pino, A. D., Knop, F. K., Piro, S., Rabuazzo, A. M., & Purrello, F. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.01.013 · Cited by 36
Nakamura, Y., Turin, T. C., Kita, Y., Tamaki, S., Tsujita, Y., Kadowaki, T., Murakami, Y., Okamura, T., & Ueshima, H. (2007) · Circulation Journal · doi:10.1253/circj.71.776 · Cited by 36
Significance of HbA1c and its measurement in the diagnosis of diabetes mellitus: US experience
Juarez, D. T., Demaris, K., Goo, R., Mnatzaganian, C. L., & Smith, H. W. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s39092 · Cited by 35
Stolz, A., Hedeland, Y., Salzer, L., Römer, J., Heiene, R., Leclercq, L., Cottet, H., Bergquist, J., & Neusüß, C. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c01350 · Cited by 35
Atlas, S. J., Kim, K., Nhan, E., Touchette, D. R., Moradi, A., Agboola, F., Rind, D. M., Beaudoin, F. L., & Pearson, S. D. (2023) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2023.29.5.569 · Cited by 33
Multi-omics approaches for biomarker discovery and precision diagnosis of prediabetes
Song, J., Wang, C., Zhao, T., Zhang, Y., Xing, J., Zhao, X., Zhang, Y., & Zhang, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1520436 · Cited by 36
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes
Calanna, S., Scicali, R., Pino, A. D., Knop, F. K., Piro, S., Rabuazzo, A. M., & Purrello, F. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0555-5 · Cited by 34
Carroll, H. A., Betts, J. A., & Johnson, L. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114516003688 · Cited by 34
Ahmed, D., Sharma, M., Kumar, V., Bajaj, H. K., & Verma, A. (2014) · Journal of Food Science and Technology · doi:10.1007/s13197-014-1676-0 · Cited by 31
RetractedValdés, S., Botas, P., Delgado, E., Álvarez, F. V., & Díaz-Cadórniga, F. J. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.07.002 · Cited by 29
Venkatesan, T., & Pillai, S. S. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00145.x · Cited by 30
Update on pre-diabetes: Focus on diagnostic criteria and cardiovascular risk
Pino, A. D., Urbano, F., Piro, S., Purrello, F., & Rabuazzo, A. M. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i18.423 · Cited by 30
Kim, C., Kim, H., Kim, E., Bae, S., Choe, J., & Park, J. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.06.009 · Cited by 36
What can blood biomarkers tell us about cardiovascular risk in obstructive sleep apnea?
Freitas, I. G. D. A., de Bruin, P. F. C., Bittencourt, L., de Bruin, V. M. S., & Tufik, S. B. (2015) · Sleep And Breathing · doi:10.1007/s11325-015-1143-9 · Cited by 26
An Analytics‐Driven Approach for Optimal Individualized Diabetes Screening
Kamalzadeh, H., Ahuja, V., Hahsler, M., & Bowen, M. E. (2021) · Production and Operations Management · doi:10.1111/poms.13422 · Cited by 24
HbA1c, fasting plasma glucose and the prediction of diabetes: Inter99, AusDiab and D.E.S.I.R.
Soulimane, S., Simon, D., Shaw, J. E., Witte, D. R., Zimmet, P., Vol, S., Borch‐Johnsen, K., Magliano, D. J., Vistisen, D., & Balkau, B. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.06.003 · Cited by 26
Feleke, B. E., Feleke, T. E., Kassahun, M. B., Adane, W. G., Fentahun, N., Girma, A., Alebachew, A., Misgan, E., Desyibelew, H. D., Bayih, M. T., et al. (2021) · BioMed Research International · doi:10.1155/2021/6691819 · Cited by 24
New-Onset Diabetes after Hemodialysis Initiation: Impact on Survival
Salifu, M. O., Abbott, K. C., Aytug, S., Hayat, A., Haria, D. M., Shah, S. A., Friedman, E. A., Delano, B. G., McFarlane, S. I., Hurst, F. P., et al. (2010) · American Journal of Nephrology · doi:10.1159/000276542 · Cited by 24
Davidson, M. B., & Kahn, R. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1370 · Cited by 23
¡Viva Maryvale!: A Multilevel, Multisector Model to Community-Based Diabetes Prevention
Soltero, E. G., Ramos, C., Williams, A. N., Hooker, E., Mendez, J., Wildy, H., Davis, K., Hernandez, V., Contreras, O. A., Silva, M. D. L. S. D., et al. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.07.034 · Cited by 22
Kim, H., Bae, S., & Choe, J. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.2.151 · Cited by 22
Lee, J., Lee, Y. A., Kim, J. H., Lee, S. Y., Shin, C. H., & Yang, S. W. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0046 · Cited by 22
Churuangsuk, C., Lean, M. E. J., & Combet, E. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02122-1 · Cited by 24
The impact of acute illness on HbA1c determination of undiagnosed diabetes
Thakker, U., Ellman, T., Magleby, R., Graff, K., Kelson, J. R., & Silverman, R. A. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2315 · Cited by 22
Meme, N., Amwayi, S. A., Nganga, Z., & Buregyeya, E. (2015) · Pan African Medical Journal · doi:10.11604/pamj.2015.22.286.7395 · Cited by 23
Wong, K. Y. C., Wong, V., Ho, J., Torpy, D., Mclean, M., & Cheung, W. N. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03654.x · Cited by 24
Obesity, diabetes and longevity in the Gulf: Is there a Gulf Metabolic Syndrome?
Guy, G. W., Nunn, A. V. W., Thomas, E. L., & Bell, J. D. (2009) · International Journal of Diabetes Mellitus · doi:10.1016/j.ijdm.2009.05.001 · Cited by 19
Motta, M., Bennati, E., Cardillo, E., Ferlito, L., & Malaguarnera, M. (2009) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2009.01.012 · Cited by 19
HMC Ameliorates Hyperglycemia via Acting PI3K/AKT Pathway and Improving FOXO1 Pathway in ob/ob Mice
Yoo, J., Park, J. E., & Han, J.-S. (2023) · Nutrients · doi:10.3390/nu15092023 · Cited by 18
Ramachandran, A., Snehalatha, C., Shetty, A. S., & Nanditha, A. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03392.x · Cited by 18
Jones, D. W., & Hall, J. E. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.113746 · Cited by 18
Nakajima, K., & Suwa, K. (2014) · Endocrine Research · doi:10.3109/07435800.2014.934962 · Cited by 16
Types of diabetes mellitus, mechanism of insulin resistance and associated complications
Jadon, A. S., Kaushik, M. P., Anitha, K., Bhatt, S., Bhadauriya, P., & Sharma, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13195-0.00001-6 · Cited by 29
Cosson, E., Nguyen, T. M., Hamo-Tchatchouang, E., Banu, I., Chiheb, S., Charnaux, N., & Valensi, P. E. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03215.x · Cited by 18
Optical Coherence Tomography Angiography in Type 1 Diabetes Mellitus. Report 4: Glycated Haemoglobin
Bernal-Morales, C., Alé-Chilet, A., Martín, R., Barraso, M., Hernández, T., Oliva, C., Vinagre, I., Ortega, E., Figueras‐Roca, M., Sala‐Puigdollers, A., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11091537 · Cited by 17
Social support, strain, and glycemic control: A path analysis
Maki, K. G. (2020) · Personal Relationships · doi:10.1111/pere.12333 · Cited by 16
Ehehalt, S., Wiegand, S., Körner, A., Schweizer, R., Liesenkötter, K., Partsch, C., Blumenstock, G., Spielau, U., Denzer, C., Ranke, M. B., et al. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12461 · Cited by 16
Kawahara, T., Imawatari, R., Kawahara, C., Inazu, T., & Suzuki, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122698 · Cited by 16
Manley, S. E., ROUND, R. A., & Smith, J. M. (2006) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/000456306776021508 · Cited by 16
Inoue, K., Inoue, M., Matsumoto, M., & Akimoto, K. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03536.x · Cited by 15
Jelinek, G. A., Weiland, T. J., Moore, G., Tan, G., Maslin, M., Bowman, K., Ward, G. M., & O’Dea, K. (2010) · Emergency Medicine Australasia · doi:10.1111/j.1742-6723.2010.01333.x · Cited by 14
Implications of Risk Stratification for Diabetes Prevention
Gregg, E. W., Geiss, L. S., Zhang, P., Zhuo, X., Williamson, D. F., & Albright, A. L. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.12.012 · Cited by 15
Glycated haemoglobin (HbA1c): today and tomorrow
Roszyk, L., Faye, B., Sapin, V., Somda, F., & Tauveron, I. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.06.004 · Cited by 14
Kim, T. N., Park, M. S., Lee, S. K., Yang, S. J., Lee, K. W., Nam, M. S., Park, Y. S., Woo, J., Kim, Y. S., & Baik, S. H. (2012) · Endocrine · doi:10.1007/s12020-012-9666-3 · Cited by 13
Haines, M. R. (2020) · Pilot and Feasibility Studies · doi:10.1186/s40814-020-00571-8 · Cited by 14
Observations and Recommendations for Community-Based Diabetes Screenings
West, B., Parikh, P., Arniella, G., & Horowitz, C. R. (2010) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721710386973 · Cited by 13
Metadata
- Authors
- Edelman, D., Olsen, M. K., Dudley, T. K., Harris, A. C., & Oddone, E. Z.
- Affiliations
- Duke University (US)
- Durham VA Medical Center (US)
- Corresponding author
- Edelman, David
- Venue
- Journal of General Internal Medicine
- Published
- 2004-12
- Volume
- 19
- Issue
- 12
- Pages
- 1175-1180
- ISSN
- 0884-8734 (ISSN-L)
- 1525-1497
- PMC
- PMC1492588
- OpenAlex
- W2044864388
- Cited by
- 213
- References
- 38
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 11 · 2022: 4 · 2021: 7 · 2020: 11 · 2019: 8 · 2018: 7 · 2017: 4 · 2016: 17 · 2015: 11 · 2014: 14 · 2013: 12 · 2012: 10
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of General Internal Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- HbA1c, type 2 diabetes, diabetes screening, diabetes risk prediction, risk stratification, diabetes incidence, fasting blood glucose, body mass index, veterans, outpatients, undiagnosed diabetes, glycemic control, veterans health system, prediabetes, Diabetes Prevention Program, prediabetes screening
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Type 2, Follow-Up Studies, Glycated Hemoglobin, Humans, Middle Aged, Obesity, Prospective Studies, Regression Analysis, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review